SLC31A1 and lung cancer: Furthermore, the C allele, which was associated with poor outcomes of platinum-based therapy in NSCLC patients, correlated with reductions in luciferase activity in reporter assay and in SLC31A1 transcript expression in clinical lung cancer tissues as well.